Table 2.
Diagnostic Group | Number (%) | Number of Respondents (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0 (%) |
1–5 (%) |
6–10 (%) |
11–20 (%) |
21–30 (%) |
31–40 (%) |
41–60 (%) |
61–80 (%) |
≥81 (%) |
Unknown | ||
Dementia | 13 (48.2%) | 4 (14.8%) | 0 | 1 (3.7%) | 5 (18.5%) | 2 (7.4%) | 0 | 0 | 1 (3.7%) | 1 (3.7%) | 26/27 (96.3%) |
Neurodegenerative diseases | 4 (14.8%) | 3 (11.1%) | 4 (14.8%) | 7 (25.9%) | 2 (7.4%) | 3 (11.1%) | 0 | 0 | 1 (3.7%) | 3 (11.1%) | 24/27 (88.9%) |
Traumatic brain injury | 3 (11.1%) | 9 (33.3%) | 8 (29.6%) | 3 (11.1%) | 0 | 1 (3.7%) | 0 | 0 | 0 | 3 (11.1%) | 24/27 (88.9%) |
Stroke | 3 (11.1%) | 0 | 3 (11.1%) | 5 (18.5%) | 5 (18.5%) | 4 (14.8%) | 3 (11.1%) | 1 (3.7%) | 1 (3.7%) | 2 (7.4%) | 25/27 (92.6%) |
Oncology | 11 40.7%) | 9 (33.3%) | 1 (3.7%) | 3 (11.1%) | 1 (3.7%) | 0 | 1 (3.7%) | 0 | 0 | 1 (3.7%) | 26/27 (96.3%) |
Congenital neurological conditions | 13 (48.2%) | 7 (25.9%) | 3 (11.1%) | 0 | 1 (3.7%) | 0 | 0 | 0 | 0 | 3 (11.1%) | 23/27 (85.2%) |